Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready
Scai Therapeutics Co. Ltd. currently has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 3 distinct examiners and are distributed across 3 distinct art units. BAEK, BONG-SOOK is the busiest examiner for the company, holding 2 pending office actions.
The involvement of 3 distinct examiners for the pending office actions suggests a mix of concentrated and distributed prosecution. BAEK, BONG-SOOK manages 2 pending office actions, allowing the company to develop a consistent strategy for those matters. The remaining actions are each handled by a different examiner, requiring the applicant to adapt to their specific styles.
The distribution across 3 distinct art units indicates that the company's technology spans several specialized areas within the Biotechnology & Pharmaceuticals field. This requires the legal team to be familiar with the procedural standards of different USPTO divisions. Managing the 4 pending office actions in this environment requires careful coordination across the examiners and art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| Double-patenting + other | 2 (50%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAEK, BONG-SOOK | 2 | 41.7% | +69.9% |
| ARMSTRONG, SUSANNAH SIPPLE | 1 | 30.0% | +53.1% |
| WORSHAM, JESSICA N | 1 | 56.3% | +56.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18838139 | STRUCTURE OF POLYMERIC HYALURONIC ACID, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION COMPRISING SAME | ARMSTRONG, SUSANNAH SIPPLE | — |
| 18578902 | COSMETIC COMPOSITION COMPRISING MOLECULAR AGGREGATES OF BILE ACIDS OR BILE ACID SALTS | BAEK, BONG-SOOK | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18838139 | STRUCTURE OF POLYMERIC HYALURONIC ACID, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION COMPRISING SAME | ARMSTRONG, SUSANNAH SIPPLE | — |
| 18421490 | NANO-MOLECULE AGGREGATE CONSISTING OF ORGANIC MATERIAL, INORGANIC MATERIAL OR SALT THEREOF AND PREPARATION METHOD THEREFOR | WORSHAM, JESSICA N | — |
| 18578902 | COSMETIC COMPOSITION COMPRISING MOLECULAR AGGREGATES OF BILE ACIDS OR BILE ACID SALTS | BAEK, BONG-SOOK | — |
| 18579262 | MOLECULAR ASSOCIATION OF BILE ACID OR BILE SALT AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR LOCALLY REDUCING FAT | BAEK, BONG-SOOK | — |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| 1611 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18838139 | STRUCTURE OF POLYMERIC HYALURONIC ACID, METHOD FOR PREPARING SAME, AND COSMETIC COMPOSITION COMPRISING SAME | ARMSTRONG, SUSANNAH SIPPLE | — | §101§102§103§112DP | Non-Final OA | — | Pending | Aug 13, 2024 |
| 18421490 | NANO-MOLECULE AGGREGATE CONSISTING OF ORGANIC MATERIAL, INORGANIC MATERIAL OR SALT THEREOF AND PREPARATION METHOD THEREFOR | WORSHAM, JESSICA N | 1615 | §102§112DP | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18578902 | COSMETIC COMPOSITION COMPRISING MOLECULAR AGGREGATES OF BILE ACIDS OR BILE ACID SALTS | BAEK, BONG-SOOK | 1611 | §102§103§112 | Final Rejection | — | Pending | Jan 12, 2024 |
| 18579262 | MOLECULAR ASSOCIATION OF BILE ACID OR BILE SALT AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR LOCALLY REDUCING FAT | BAEK, BONG-SOOK | 1693 | §102§103§112DP | Non-Final OA | — | Pending | Jan 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial